TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Should You Try to Catch This Falling Knife?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) just reminded investors that cheap stocks can get a lot cheaper very quickly.

    Read more »

    The Motley Fool
    Dividend Stocks

    3 Canadian Stocks to Buy in a Donald Trump World

    A Trump presidency is good news for TransCanada Corporation (TSX:TRP)(NYSE:TRP), Barrick Gold Corp. (TSX:ABX)(NYSE:ABX), and one other stock.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Is in Trouble Again: Down 25%

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is a lottery ticket with huge upside and downside potential.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals International Inc. Q3 Earnings Preview: It’s Gonna Be Ugly

    What to expect from the market's most beaten-up stock, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) next Tuesday.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. in Talks to Sell $10 Billion Division: What Now?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) had big news on Tuesday. Investors need to be patient and wait.

    Read more »

    The Motley Fool
    Investing

    The Real Reason Why Bill Ackman Still Holds Valeant Pharmaceuticals Intl Inc.

    Valeant Pharmaceutical Intl Inc. (TSX:VRX)(NYSE:VRX) has fallen so much that there might be some value to be had. Bill Ackman…

    Read more »

    The Motley Fool
    Investing

    Why Valeant Pharmaceuticals Intl Inc. Is the Best Contrarian Pick for 2017

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is a newly minted value stock, which offers an interesting entry point for long-term investors.…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Turnaround Candidate or Racing to the Bottom?

    Valent Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is making all of the right business decisions, but it may not be enough to…

    Read more »

    The Motley Fool
    Investing

    Concordia International Corp.: A Safe Buy?

    Concordia International Corp. (TSX:CXR)(NASDAQ:CXRX) is a risky, debt-ridden company that could grow quite handsomely if a series of steps are…

    Read more »

    The Motley Fool
    Investing

    Should You Buy Valeant Pharmaceuticals Intl Inc.?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is a risky buy, even if it can get its debt under control--and that's a…

    Read more »

    The Motley Fool
    Dividend Stocks

    3 Dirty Secrets Bay Street Doesn’t Want You to Know

    Be wary of what Bay Street bankers and analysts tell you, especially when they tout stocks such as Valeant Pharmaceuticals…

    Read more »

    The Motley Fool
    Investing

    More Problems for Valeant Pharmaceuticals Intl Inc.

    Problems continue to mount for Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX). The company now faces a number of lawsuits in addition…

    Read more »